Urologix, Inc. (ULGX) Reports Q4 Loss of $0.08
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Price: $0.00 --0%
Financial Fact:
Research and development: 298K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Research and development: 298K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q4 EPS of ($0.08), versus ($0.05) reported last year. Revenue for the quarter came in at $4.65 million, versus $3.32 million reported last year.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- Marlin Business Services (MRLN) Reports Q2 Loss of $1.40
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
